iClinic Pro Limited


Acorah Software Products - Accounts Production 11.15.096 true true No description of principal activity 18 December 2019 31 December 2020 31 December 2020 12369383 Mr Mike Boyce Ms Emma Dwane iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12369383 2019-12-17 12369383 2020-12-31 12369383 2019-12-18 2020-12-31 12369383 frs-core:CurrentFinancialInstruments 2020-12-31 12369383 frs-core:CurrentFinancialInstruments 2019-12-18 2020-12-31 12369383 frs-core:Non-currentFinancialInstruments 2020-12-31 12369383 frs-core:Non-currentFinancialInstruments 2019-12-18 2020-12-31 12369383 frs-core:CurrentFinancialInstruments 2019-12-18 2020-12-31 12369383 frs-core:CurrentFinancialInstruments 2020-12-31 12369383 frs-core:AfterOneYear 2019-12-18 2020-12-31 12369383 frs-core:BetweenOneFiveYears 2019-12-18 2020-12-31 12369383 frs-core:BetweenOneFiveYears 2020-12-31 12369383 frs-core:ComputerEquipment 2020-12-31 12369383 frs-core:ComputerEquipment 2019-12-18 2020-12-31 12369383 frs-core:ComputerEquipment 2019-12-17 12369383 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2020-12-31 12369383 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2019-12-18 2020-12-31 12369383 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2019-12-17 12369383 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2020-12-31 12369383 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2019-12-18 2020-12-31 12369383 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2019-12-17 12369383 frs-core:FurnitureFittings 2020-12-31 12369383 frs-core:FurnitureFittings 2019-12-18 2020-12-31 12369383 frs-core:FurnitureFittings 2019-12-17 12369383 frs-core:NetGoodwill 2020-12-31 12369383 frs-core:NetGoodwill 2019-12-18 2020-12-31 12369383 frs-core:NetGoodwill 2019-12-17 12369383 frs-core:InvestmentPropertyIncludedWithinPPE 2020-12-31 12369383 frs-core:InvestmentPropertyIncludedWithinPPE 2019-12-18 2020-12-31 12369383 frs-core:InvestmentPropertyIncludedWithinPPE 2019-12-17 12369383 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2020-12-31 12369383 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2019-12-18 2020-12-31 12369383 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2019-12-17 12369383 frs-core:OwnedOrFreeholdAssets frs-core:LandBuildings 2020-12-31 12369383 frs-core:OwnedOrFreeholdAssets frs-core:LandBuildings 2019-12-18 2020-12-31 12369383 frs-core:OwnedOrFreeholdAssets frs-core:LandBuildings 2019-12-17 12369383 frs-core:MoreThanFiveYears 2019-12-18 2020-12-31 12369383 frs-core:MoreThanFiveYears 2020-12-31 12369383 frs-core:MotorVehicles 2020-12-31 12369383 frs-core:MotorVehicles 2019-12-18 2020-12-31 12369383 frs-core:MotorVehicles 2019-12-17 12369383 frs-core:OtherResidualIntangibleAssets 2020-12-31 12369383 frs-core:OtherResidualIntangibleAssets 2019-12-18 2020-12-31 12369383 frs-core:OtherResidualIntangibleAssets 2019-12-17 12369383 frs-core:PlantMachinery 2020-12-31 12369383 frs-core:PlantMachinery 2019-12-18 2020-12-31 12369383 frs-core:PlantMachinery 2019-12-17 12369383 frs-core:Secured 2020-12-31 12369383 frs-core:Unsecured 2020-12-31 12369383 frs-core:WithinOneYear 2019-12-18 2020-12-31 12369383 frs-core:WithinOneYear 2020-12-31 12369383 frs-core:CapitalRedemptionReserve 2019-12-18 2020-12-31 12369383 frs-core:CapitalRedemptionReserve 2019-12-17 12369383 frs-core:CapitalRedemptionReserve 2020-12-31 12369383 frs-core:OtherReservesSubtotal 2019-12-18 2020-12-31 12369383 frs-core:OtherReservesSubtotal 2019-12-17 12369383 frs-core:OtherReservesSubtotal 2020-12-31 12369383 frs-core:RevaluationReserve 2019-12-18 2020-12-31 12369383 frs-core:RevaluationReserve 2019-12-17 12369383 frs-core:RevaluationReserve 2020-12-31 12369383 frs-core:SharePremium 2019-12-18 2020-12-31 12369383 frs-core:SharePremium 2019-12-17 12369383 frs-core:SharePremium 2020-12-31 12369383 frs-core:ShareCapital 2019-12-18 2020-12-31 12369383 frs-core:ShareCapital 2019-12-17 12369383 frs-core:ShareCapital 2020-12-31 12369383 frs-core:RetainedEarningsAccumulatedLosses 2019-12-18 2020-12-31 12369383 frs-core:RetainedEarningsAccumulatedLosses 2019-12-17 12369383 frs-core:RetainedEarningsAccumulatedLosses 2020-12-31 12369383 frs-bus:HighestPaidDirector 2019-12-18 2020-12-31 12369383 frs-bus:PrivateLimitedCompanyLtd 2019-12-18 2020-12-31 12369383 frs-bus:CompanyLimitedByGuarantee 2019-12-18 2020-12-31 12369383 frs-bus:LimitedLiabilityPartnershipLLP 2019-12-18 2020-12-31 12369383 frs-bus:FullAccounts 2019-12-18 2020-12-31 12369383 frs-bus:AbbreviatedAccounts 2019-12-18 2020-12-31 12369383 frs-bus:Micro-entities 2019-12-18 2020-12-31 12369383 frs-bus:EntityHasNeverTraded 2019-12-18 2020-12-31 12369383 frs-bus:EntityNoLongerTradingButTradedInPast 2019-12-18 2020-12-31 12369383 frs-bus:Audited 2019-12-18 2020-12-31 12369383 frs-bus:AuditExempt-NoAccountantsReport 2019-12-18 2020-12-31 12369383 frs-bus:AuditExemptWithAccountantsReport 2019-12-18 2020-12-31 12369383 frs-bus:OrdinaryShareClass1 2019-12-18 2020-12-31 12369383 frs-bus:OrdinaryShareClass1 2019-12-17 12369383 frs-bus:OrdinaryShareClass1 2020-12-31 12369383 frs-bus:OrdinaryShareClass2 2019-12-18 2020-12-31 12369383 frs-bus:OrdinaryShareClass2 2019-12-17 12369383 frs-bus:OrdinaryShareClass2 2020-12-31 12369383 frs-bus:OrdinaryShareClass3 2019-12-18 2020-12-31 12369383 frs-bus:OrdinaryShareClass3 2019-12-17 12369383 frs-bus:OrdinaryShareClass3 2020-12-31 12369383 frs-bus:OrdinaryShareClass4 2019-12-18 2020-12-31 12369383 frs-bus:OrdinaryShareClass4 2019-12-17 12369383 frs-bus:OrdinaryShareClass4 2020-12-31 12369383 frs-bus:OrdinaryShareClass5 2019-12-18 2020-12-31 12369383 frs-bus:OrdinaryShareClass5 2019-12-17 12369383 frs-bus:OrdinaryShareClass5 2020-12-31 12369383 frs-bus:PreferenceShareClass1 2019-12-18 2020-12-31 12369383 frs-bus:PreferenceShareClass1 2019-12-17 12369383 frs-bus:PreferenceShareClass1 2020-12-31 12369383 frs-bus:PreferenceShareClass2 2019-12-18 2020-12-31 12369383 frs-bus:PreferenceShareClass2 2019-12-17 12369383 frs-bus:PreferenceShareClass2 2020-12-31 12369383 frs-bus:PreferenceShareClass3 2019-12-18 2020-12-31 12369383 frs-bus:PreferenceShareClass3 2019-12-17 12369383 frs-bus:PreferenceShareClass3 2020-12-31 12369383 frs-bus:PreferenceShareClass4 2019-12-18 2020-12-31 12369383 frs-bus:PreferenceShareClass4 2019-12-17 12369383 frs-bus:PreferenceShareClass4 2020-12-31 12369383 frs-bus:PreferenceShareClass5 2019-12-18 2020-12-31 12369383 frs-bus:PreferenceShareClass5 2019-12-17 12369383 frs-bus:PreferenceShareClass5 2020-12-31 12369383 1 2019-12-18 2020-12-31 12369383 dpl-frs:CostSales 2019-12-18 2020-12-31 12369383 dpl-frs:CostSales 2019-12-17 12369383 dpl-frs:CostSales 2020-12-31 12369383 dpl-frs:DistributionCosts 2019-12-18 2020-12-31 12369383 dpl-frs:AdministrativeExpenses 2019-12-18 2020-12-31 12369383 frs-bus:Director1 2019-12-18 2020-12-31 12369383 frs-bus:Director1 2019-12-17 12369383 frs-bus:Director1 2020-12-31 12369383 frs-bus:Director2 2019-12-18 2020-12-31 12369383 frs-bus:Director2 2019-12-17 12369383 frs-bus:Director2 2020-12-31 12369383 1 2019-12-18 2020-12-31 12369383 frs-core:CurrentFinancialInstruments 1 2020-12-31 12369383 frs-core:Non-currentFinancialInstruments 1 2020-12-31 12369383 2 2019-12-18 2020-12-31 12369383 frs-core:CurrentFinancialInstruments 2 2020-12-31 12369383 frs-core:Non-currentFinancialInstruments 2 2020-12-31 12369383 3 2019-12-18 2020-12-31 12369383 frs-core:CurrentFinancialInstruments 3 2020-12-31 12369383 frs-core:Non-currentFinancialInstruments 3 2020-12-31 12369383 4 2019-12-18 2020-12-31 12369383 frs-core:CurrentFinancialInstruments 4 2020-12-31 12369383 frs-core:Non-currentFinancialInstruments 4 2020-12-31 12369383 5 2019-12-18 2020-12-31 12369383 frs-core:CurrentFinancialInstruments 5 2020-12-31 12369383 frs-core:Non-currentFinancialInstruments 5 2020-12-31 12369383 6 2019-12-18 2020-12-31 12369383 frs-core:CurrentFinancialInstruments 6 2020-12-31 12369383 frs-core:Non-currentFinancialInstruments 6 2020-12-31 12369383 7 2019-12-18 2020-12-31 12369383 frs-core:CurrentFinancialInstruments 7 2020-12-31 12369383 frs-core:Non-currentFinancialInstruments 7 2020-12-31 12369383 8 2019-12-18 2020-12-31 12369383 frs-core:CurrentFinancialInstruments 8 2020-12-31 12369383 frs-core:Non-currentFinancialInstruments 8 2020-12-31 12369383 9 2019-12-18 2020-12-31 12369383 frs-core:CurrentFinancialInstruments 9 2020-12-31 12369383 frs-core:Non-currentFinancialInstruments 9 2020-12-31 12369383 dpl-frs:Item1 2019-12-18 2020-12-31 12369383 dpl-frs:Item1 2019-12-17 12369383 dpl-frs:Item1 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item1 2019-12-18 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item1 2019-12-17 12369383 dpl-frs:CostSales dpl-frs:Item1 2020-12-31 12369383 dpl-frs:DistributionCosts dpl-frs:Item1 2019-12-18 2020-12-31 12369383 dpl-frs:AdministrativeExpenses dpl-frs:Item1 2019-12-18 2020-12-31 12369383 dpl-frs:Item2 2019-12-18 2020-12-31 12369383 dpl-frs:Item2 2019-12-17 12369383 dpl-frs:Item2 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item2 2019-12-18 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item2 2019-12-17 12369383 dpl-frs:CostSales dpl-frs:Item2 2020-12-31 12369383 dpl-frs:DistributionCosts dpl-frs:Item2 2019-12-18 2020-12-31 12369383 dpl-frs:AdministrativeExpenses dpl-frs:Item2 2019-12-18 2020-12-31 12369383 dpl-frs:Item3 2019-12-18 2020-12-31 12369383 dpl-frs:Item3 2019-12-17 12369383 dpl-frs:Item3 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item3 2019-12-18 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item3 2019-12-17 12369383 dpl-frs:CostSales dpl-frs:Item3 2020-12-31 12369383 dpl-frs:DistributionCosts dpl-frs:Item3 2019-12-18 2020-12-31 12369383 dpl-frs:AdministrativeExpenses dpl-frs:Item3 2019-12-18 2020-12-31 12369383 dpl-frs:Item4 2019-12-18 2020-12-31 12369383 dpl-frs:Item4 2019-12-17 12369383 dpl-frs:Item4 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item4 2019-12-18 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item4 2019-12-17 12369383 dpl-frs:CostSales dpl-frs:Item4 2020-12-31 12369383 dpl-frs:DistributionCosts dpl-frs:Item4 2019-12-18 2020-12-31 12369383 dpl-frs:AdministrativeExpenses dpl-frs:Item4 2019-12-18 2020-12-31 12369383 dpl-frs:Item5 2019-12-18 2020-12-31 12369383 dpl-frs:Item5 2019-12-17 12369383 dpl-frs:Item5 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item5 2019-12-18 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item5 2019-12-17 12369383 dpl-frs:CostSales dpl-frs:Item5 2020-12-31 12369383 dpl-frs:DistributionCosts dpl-frs:Item5 2019-12-18 2020-12-31 12369383 dpl-frs:AdministrativeExpenses dpl-frs:Item5 2019-12-18 2020-12-31 12369383 dpl-frs:Item6 2019-12-18 2020-12-31 12369383 dpl-frs:Item6 2019-12-17 12369383 dpl-frs:Item6 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item6 2019-12-18 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item6 2019-12-17 12369383 dpl-frs:CostSales dpl-frs:Item6 2020-12-31 12369383 dpl-frs:DistributionCosts dpl-frs:Item6 2019-12-18 2020-12-31 12369383 dpl-frs:AdministrativeExpenses dpl-frs:Item6 2019-12-18 2020-12-31 12369383 dpl-frs:Item7 2019-12-18 2020-12-31 12369383 dpl-frs:Item7 2019-12-17 12369383 dpl-frs:Item7 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item7 2019-12-18 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item7 2019-12-17 12369383 dpl-frs:CostSales dpl-frs:Item7 2020-12-31 12369383 dpl-frs:DistributionCosts dpl-frs:Item7 2019-12-18 2020-12-31 12369383 dpl-frs:AdministrativeExpenses dpl-frs:Item7 2019-12-18 2020-12-31 12369383 dpl-frs:Item8 2019-12-18 2020-12-31 12369383 dpl-frs:Item8 2019-12-17 12369383 dpl-frs:Item8 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item8 2019-12-18 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item8 2019-12-17 12369383 dpl-frs:CostSales dpl-frs:Item8 2020-12-31 12369383 dpl-frs:DistributionCosts dpl-frs:Item8 2019-12-18 2020-12-31 12369383 dpl-frs:AdministrativeExpenses dpl-frs:Item8 2019-12-18 2020-12-31 12369383 dpl-frs:Item9 2019-12-18 2020-12-31 12369383 dpl-frs:Item9 2019-12-17 12369383 dpl-frs:Item9 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item9 2019-12-18 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item9 2019-12-17 12369383 dpl-frs:CostSales dpl-frs:Item9 2020-12-31 12369383 dpl-frs:DistributionCosts dpl-frs:Item9 2019-12-18 2020-12-31 12369383 dpl-frs:AdministrativeExpenses dpl-frs:Item9 2019-12-18 2020-12-31 12369383 dpl-frs:Item10 2019-12-18 2020-12-31 12369383 dpl-frs:Item10 2019-12-17 12369383 dpl-frs:Item10 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item10 2019-12-18 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item10 2019-12-17 12369383 dpl-frs:CostSales dpl-frs:Item10 2020-12-31 12369383 dpl-frs:DistributionCosts dpl-frs:Item10 2019-12-18 2020-12-31 12369383 dpl-frs:AdministrativeExpenses dpl-frs:Item10 2019-12-18 2020-12-31 12369383 dpl-frs:Item11 2019-12-18 2020-12-31 12369383 dpl-frs:Item11 2019-12-17 12369383 dpl-frs:Item11 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item11 2019-12-18 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item11 2019-12-17 12369383 dpl-frs:CostSales dpl-frs:Item11 2020-12-31 12369383 dpl-frs:DistributionCosts dpl-frs:Item11 2019-12-18 2020-12-31 12369383 dpl-frs:AdministrativeExpenses dpl-frs:Item11 2019-12-18 2020-12-31 12369383 dpl-frs:Item12 2019-12-18 2020-12-31 12369383 dpl-frs:Item12 2019-12-17 12369383 dpl-frs:Item12 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item12 2019-12-18 2020-12-31 12369383 dpl-frs:CostSales dpl-frs:Item12 2019-12-17 12369383 dpl-frs:CostSales dpl-frs:Item12 2020-12-31 12369383 dpl-frs:DistributionCosts dpl-frs:Item12 2019-12-18 2020-12-31 12369383 dpl-frs:AdministrativeExpenses dpl-frs:Item12 2019-12-18 2020-12-31 12369383 1 2019-12-18 2020-12-31 12369383 frs-countries:EnglandWales 2019-12-18 2020-12-31
Registered number: 12369383
iClinic Pro Limited
Financial Statements
For the Period 18 December 2019 to 31 December 2020
Gooch Maloney & Partners Limited

Chartered Tax Advisers and Accountants

Streathbourne House
Redehall Road
Smallfield
Surrey
RH6 9QA
Balance Sheet
Registered number: 12369383
31 December 2020
£
Current assets 100
NET CURRENT ASSETS 100
TOTAL ASSETS LESS CURRENT LIABILITIES 100
NET ASSETS 100
CAPITAL AND RESERVES 100
Notes
1. Average Number of Employees
Average number of employees, including directors, during the year was as follows: 2
2
2. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
The above loan is unsecured, interest free and repayable on demand.
3. General Information
iClinic Pro Limited is a private company, limited by shares, incorporated in England & Wales, registered number 12369383 . The registered office is 76 Marmion Road, Hove, BN3 5FT.
For the period ending 31 December 2020 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors' responsibilities:
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr Mike Boyce
Director
26 August 2021
Page 1